These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33577950)

  • 1. Improving the production of NAD
    Yang L; Mu X; Nie Y; Xu Y
    Metab Eng; 2021 Mar; 64():122-133. PubMed ID: 33577950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo biosynthesis of α-aminoadipate via multi-strategy metabolic engineering in Escherichia coli.
    Zhang Y; Liu M; Cai B; He K; Wang M; Chen B; Tan T
    Microbiologyopen; 2022 Oct; 11(5):e1301. PubMed ID: 36314756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic engineering of Escherichia coli for biosynthesis of β-nicotinamide mononucleotide from nicotinamide.
    Liu Y; Yasawong M; Yu B
    Microb Biotechnol; 2021 Nov; 14(6):2581-2591. PubMed ID: 34310854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic engineering of Escherichia coli for L-malate production anaerobically.
    Jiang Y; Zheng T; Ye X; Xin F; Zhang W; Dong W; Ma J; Jiang M
    Microb Cell Fact; 2020 Aug; 19(1):165. PubMed ID: 32811486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic engineering of Escherichia coli: increase of NADH availability by overexpressing an NAD(+)-dependent formate dehydrogenase.
    Berríos-Rivera SJ; Bennett GN; San KY
    Metab Eng; 2002 Jul; 4(3):217-29. PubMed ID: 12616691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolic engineering for the salvage synthesis of NAD(.).
    Honda K; Hara N; Cheng M; Nakamura A; Mandai K; Okano K; Ohtake H
    Metab Eng; 2016 May; 35():114-120. PubMed ID: 26912312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic engineering of cofactor flavin adenine dinucleotide (FAD) synthesis and regeneration in Escherichia coli for production of α-keto acids.
    Hou Y; Hossain GS; Li J; Shin HD; Du G; Chen J; Liu L
    Biotechnol Bioeng; 2017 Sep; 114(9):1928-1936. PubMed ID: 28498544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a single strain for in vitro salvage synthesis of NAD
    Taniguchi H; Imura M; Okano K; Honda K
    Microb Cell Fact; 2019 Apr; 18(1):75. PubMed ID: 31023312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cofactor engineering to regulate NAD
    Su L; Shen Y; Zhang W; Gao T; Shang Z; Wang M
    Microb Cell Fact; 2017 Oct; 16(1):182. PubMed ID: 29084539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of succinate yield by manipulating NADH/NAD
    Li J; Li Y; Cui Z; Liang Q; Qi Q
    Appl Microbiol Biotechnol; 2017 Apr; 101(8):3153-3161. PubMed ID: 28108762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic engineering of Escherichia coli to minimize byproduct formate and improving succinate productivity through increasing NADH availability by heterologous expression of NAD(+)-dependent formate dehydrogenase.
    Balzer GJ; Thakker C; Bennett GN; San KY
    Metab Eng; 2013 Nov; 20():1-8. PubMed ID: 23876411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of intracellular level of ATP and NADH in
    Wang X; Pan J; Wu J; Chen X; Gao C; Song W; Wei W; Liu J; Liu L
    Sheng Wu Gong Cheng Xue Bao; 2023 Aug; 39(8):3236-3252. PubMed ID: 37622358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a synthetic anaerobic respiration for reduction of xylose to xylitol using NADH output of glucose catabolism by Escherichia coli AI21.
    Iverson A; Garza E; Manow R; Wang J; Gao Y; Grayburn S; Zhou S
    BMC Syst Biol; 2016 Apr; 10():31. PubMed ID: 27083875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Escherichia coli Nicotinic Acid Mononucleotide Adenylyltransferase for Fully Active Amidated NAD Biosynthesis.
    Wang X; Zhou YJ; Wang L; Liu W; Liu Y; Peng C; Zhao ZK
    Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
    Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
    Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient production of myo-inositol in Escherichia coli through metabolic engineering.
    You R; Wang L; Shi C; Chen H; Zhang S; Hu M; Tao Y
    Microb Cell Fact; 2020 May; 19(1):109. PubMed ID: 32448266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering central metabolic modules of Escherichia coli for improving β-carotene production.
    Zhao J; Li Q; Sun T; Zhu X; Xu H; Tang J; Zhang X; Ma Y
    Metab Eng; 2013 May; 17():42-50. PubMed ID: 23500001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Protein and Metabolic Engineering Strategies for High-Level Production of O-Acetylhomoserine in Escherichia coli.
    Wei L; Wang Q; Xu N; Cheng J; Zhou W; Han G; Jiang H; Liu J; Ma Y
    ACS Synth Biol; 2019 May; 8(5):1153-1167. PubMed ID: 30973696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of NAPRTase overexpression on the total levels of NAD, the NADH/NAD+ ratio, and the distribution of metabolites in Escherichia coli.
    Berríos-Rivera SJ; San KY; Bennett GN
    Metab Eng; 2002 Jul; 4(3):238-47. PubMed ID: 12616693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design and metabolic analysis of Escherichia coli for effective production of L-tryptophan at high concentration.
    Chen L; Zeng AP
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):559-568. PubMed ID: 27599980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.